Featured Research

from universities, journals, and other organizations

Complexities Of Genetic Susceptibility To Tuberculosis Revealed

Date:
March 29, 2008
Source:
Public Library of Science
Summary:
Researchers working in Vietnam have identified a genetic variant that predisposes people to developing a lethal form of tuberculosis, tuberculous meningitis, if they are infected with a strain of TB known as the Beijing strain. The work underlines the importance of studying both sides of the complex host-pathogen interaction and its role in susceptibility to disease.

Researchers working in Vietnam have identified a genetic variant that predisposes people to developing a lethal form of tuberculosis (TB), tuberculous meningitis, if they are infected with a strain of TB known as the Beijing strain. The work underlines the importance of studying both sides of the complex host-pathogen interaction and its role in susceptibility to disease.

TB, which is caused by the bacterium Mycobacterium tuberculosis, kills over 2 million people each year. It is estimated that well over 2 million people are infected with M. tuberculosis, though the majority will never show symptoms. Some will develop a latent infection, with symptoms only showing if they become sick or immunocompromised, for example through HIV infection. A small number will develop an active TB infection, usually in their lungs, occasionally progressing to "disseminated TB" -- a condition in which failure of the immune system to control the infection allows its spread to other parts of the body.

Some of the risk factors that determine whether individuals develop active TB following exposure are well known; these include HIV infection, malnutrition and smoking. Sarah Dunstan and colleagues from the Wellcome Trust Major Overseas Programme based at the Hospital for Tropical Diseases and the Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam previously identified the link between TB susceptibility and the role of a gene involved in the immune system, known as TLR2, which is important for recognising and initiating the defensive response when the bacterium enters the body.

People with a particular variant of TLR2, commonly found in the Vietnamese population, are particularly susceptible to developing the most severe form of TB, in which the infection spreads to the meninges, the membranes that envelope the brain and the spinal cord. One in three people who develop TB meningitis die, even amongst those who receive hospital treatment.

Now, Caws and her colleagues have shown that the predisposition to developing TB meningitis appears to be strongest in people who carry the variant of TLR2 and who are infected with the specific Beijing strain of TB.

"We are seeing an increasing number of cases of the Beijing strain worldwide, a strain that is becoming more and more resistant to drugs," says Dr Caws.

The World Health Organisation estimates that around 5% of the TB cases in the world are now multi-drug resistant. In people who have multi-drug resistant TB meningitis mortality approaches 100% because there are no effective treatment regimens.

"Our findings are important because they show that we need to look at both the patient's susceptibility to the disease and the genetics of the pathogen that is infecting them at the same time," says Dr Caws. "Many studies have shown a genetic association with disease in one population but the finding has not been repeated in different populations. This might be not only because of ethnic differences in the population, but also because the pathogen populations are different.

"Understanding the mechanisms that influence our susceptibility to infectious diseases may allow us to develop more sophisticated and targeted treatments and vaccines. This is particularly important in this era of emerging 'untreatable' bacterial infections due to antibiotic resistance."

Journal reference: Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NTN, et al. (2008) The Influence of Host and Bacterial Genotype on the Development of Disseminated Disease with Mycobacterium tuberculosis. PLoS Pathog 4(3): e1000034. doi:10.1371/journal.ppat.1000034


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Cite This Page:

Public Library of Science. "Complexities Of Genetic Susceptibility To Tuberculosis Revealed." ScienceDaily. ScienceDaily, 29 March 2008. <www.sciencedaily.com/releases/2008/03/080328070127.htm>.
Public Library of Science. (2008, March 29). Complexities Of Genetic Susceptibility To Tuberculosis Revealed. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/03/080328070127.htm
Public Library of Science. "Complexities Of Genetic Susceptibility To Tuberculosis Revealed." ScienceDaily. www.sciencedaily.com/releases/2008/03/080328070127.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins